Palisade Bio (PALI)CEO sold ~$6.8K

~$6.8K

Approx. value · 3,896 sh @ $1.75

27K

Holds after · shares reported

Traded

Feb 12, 2026

Filed

Feb 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jan 9, 2026Insider · First insider buy since May 2024Director purchased ~$9.4K of PALI shares in the open market
2. Jan 16, 2026InsiderDirector purchased ~$8.4K of PALI shares in the open market
3. Feb 12, 2026 · this disclosureInsiderCEO sold ~$6.8K of PALI shares in the open market

What came next

1. Feb 12, 2026InsiderOfficer sold ~$3.5K of PALI shares in the open market
2. May 12, 2026Company filing · Form 8-K · ResultsReported its results
3. Jun 10, 2026Company filing · Form 8-K · Executive change, Bylaws or charterChanged a top executive or board member, and changed its bylaws, charter or fiscal year (and 1 more item)“On June 10, 2026 (the “Effective Date”), the Board of Directors (the “Board”) of Palisade Bio, Inc. (the “Company”) expanded the size of the Board from five to six directors and appointed Jordan Zwick to the Board.”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Palisade Bio

For Palisade Bio, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PALI page.

Other recent filings by John David Finley, CEO, CFO

• SEC Form 4 at Palisade Bio (PALI)Jul 9, 2026

The full history of John David Finley, CEO, CFO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Palisade Bio

• SEC Form 4Oct 6, 2026
• SEC Form 4Oct 6, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 4Jul 11, 2026
• SEC Form 4Jul 11, 2026
• SEC Form 4Jul 9, 2026

Everything OQRO holds on this company is on its PALI page.